Natural Killer (NK) Cell Transplantation for AML

NCT00187096 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cyclophosphamide, Fludarabine, Clofarabine, Etoposide, Interleukin-2
PROCEDURE: Natural Killer Cell Infusion
DEVICE: CliniMACS System

Sponsor

St. Jude Children's Research Hospital